Suchergebnisse - "Bekő, Gabriella"

PubPharm (90)

11

Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Fagyas, M. | Fejes, Z. | Sütő, R. | +13

12

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency

enthalten in: Frontiers in immunology | 2022

von Goda, V. | Kriván, G. | Kulcsár, A. | +9

13

Challenges and experiences of the SARS-CoV-2 pandemic in molecular diagnostics

enthalten in: Orvosi hetilap | 2021

von Zóka, A. | Tresó, B. | Bekő, G.

14

Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome

enthalten in: Acta microbiologica et immunologica Hungarica | 2021

von Gopcsa, L. | Bobek, I. | Bekő, G. | +8

15

Does the E gene provide additional information in SARS-CoV-2 PCR?

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2021

von Zóka, A. | Bekő, G.

16

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

CommentIn: Geroscience. 2022 Feb;44(1):57-61. - PMID 34935099

17

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

18

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

19

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: Age | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

20

The potential impact of Helicobacter pylori seropositivity on recombinant antigen-based Lyme serology

enthalten in: Journal of microbiological methods | 2021

von Zóka, A. | Gönczi, M. | Kádár, B. | +3